News & Updates

Hypertension, regardless of blood pressure control, appears to exert a negative influence on fecundability in women, as reported in a study.

Sacubitril/valsartan appears to be safe and beneficial in the treatment of children with heart failure (HF) attributable to systemic left ventricular systolic dysfunction (LVSD), with the drug having comparable efficacy as enalapril, according to the 52-week data from the phase 2/3 PANORAMA-HF* trial.

In stable post-MI patients without a reduced EF who have been on long-term β-blockers, interrupting the β-blocker treatment instead of continuing it leads to more hospitalizations for CV reasons and does not improve QoL, as shown in the phase III ABYSS trial presented at ESC 2024

Full results of the phase III FINEARTS-HF trial have shown that finerenone cuts the risk of worsening heart failure (HF) events and cardiovascular (CV) death in symptomatic HF with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF).

In patients with acute coronary syndrome, the use of colchicine appears be beneficial in terms of coronary plaque stabilization as assessed on optical coherence tomography, according to a study.